A putative role for the tobacco mosaic virus in smokers' resistance to COVID-19

Copyright © 2020 Elsevier Ltd. All rights reserved..

Reports from various countries suggest that tobacco smoking might protect from SARS-CoV-2 infection, since the prevalence of smoking in COVID-19 hospitalized patients is lower than in the respective general population. Apart from nicotine or other chemicals contained in tobacco smoke, we propose that a single-stranded RNA virus that infects tobacco leaves, tobacco mosaic virus (TMV), might be implicated in this effect. TMV, though non-pathogenic, is found in smokers' airways, and stimulates adaptive and innate immunity, with release of specific antibodies and interferons. The latter may have preventive and/or therapeutic effects against COVID-19. If confirmed by epidemiological and interventional studies, this might lead to the use of TMV as an immunological adjuvant against SARS-CoV-2 infection and COVID-19 disease.

Errataetall:

CommentIn: Med Hypotheses. 2020 Nov;144:110251. - PMID 33254556

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:143

Enthalten in:

Medical hypotheses - 143(2020) vom: 25. Okt., Seite 110153

Sprache:

Englisch

Beteiligte Personen:

de Bernardis, E [VerfasserIn]
Busà, L [VerfasserIn]

Links:

Volltext

Themen:

9008-11-1
Antibodies, Viral
Interferons
Journal Article
Toll-Like Receptors

Anmerkungen:

Date Completed 13.10.2020

Date Revised 28.03.2023

published: Print-Electronic

CommentIn: Med Hypotheses. 2020 Nov;144:110251. - PMID 33254556

Citation Status MEDLINE

doi:

10.1016/j.mehy.2020.110153

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM31338732X